USPTO serial 79218559
SOTIO
Reviewed by CopyMark Law Group
Reg. 5577770Status 706Registered
- Filing date
- Status date
- Registration date
- Oct 9, 2018
- Examiner
- BENMAMAN, ALICE
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with SOTIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Shane Rumbaugh
Shane Rumbaugh Rumbaugh Law PLLC2400 Ansys Drive, Suite 102Canonsburg, PA 15317United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, [ medical and veterinary ] preparations for the treatment of oncological, [ immune and autoimmune ] diseases; anticancer preparations; antitumor drugs; [ vaccines; anticancer vaccines; synthetic peptides, recombinant proteins, antibodies, antibody derivatives, antibody-drug conjugates, nucleotides and nucleotide analogs all for the treatment of oncological, immune and autoimmune diseases for medical and veterinary purposes; ] biological preparations for the treatment of oncological, [ immune and autoimmune ] diseases for medical [ and veterinary ] purposes; cellular preparations for the treatment of oncological [ , immune and autoimmune ] diseases for medical [ and veterinary ] purposes [ ; biological tissue from blood or bone marrow intended for subsequent implantation; radiopharmaceutical preparations for diagnostic, medical and veterinary use; pharmaceutical preparations for the treatment of autoimmune diseases and diabetes; clinical diagnostic reagents for medical or veterinary purposes; diagnostic agents, preparations and diagnostic kits comprised of medical diagnostic reagents, sample collection devices in the nature of specimen cups and tubes, and instructions for testing of bodily fluids and tissues for use in testing and detection of oncological, immune or autoimmune diseases for medical and veterinary purposes; drug delivery agents in the form of dissolvable tablets, capsules, gels, micelles, liposomes, particles, nanoparticles, ointment and creams, that facilitate the delivery of pharmaceutical preparations; adjuvants for medical use; dietetic substances adapted for medical use, namely, food and beverages ] | ACTIVE | — |
| 042 | Scientific services, namely, research and design in the field of antineoplastic and immunomudulating agents relating thereto; industrial analysis and research services in the field of pharmaceuticals and biotechnology; scientific research for medical [ and veterinary ] purposes in the field of oncological, [ immune and autoimmune ] diseases ; scientific research and development for medical [ and veterinary ] purposes in the area of cancerous diseases, [ autoimmune diseases or diabetes; ] pharmaceutical drug development services; conducting clinical trials for others; preclinical and clinical research in the field of oncological [ , immune and autoimmune ] diseases; analysis of toxicology and mode of action of biologicals, chemicals and combinations on animals, namely, toxicology services; pharmaceutical and biological product research, development, safety, efficacy and quality control testing services; scientific research and development for diagnostic purposes [ ; computer-aided diagnostic testing services, namely, providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; design and development of computer software and databases; design and development of computer software and databases for logistics, supply chain management and laboratory management in the fields of oncology and autoimmune disease and cancer and autoimmune research ] | ACTIVE | — |
| 044 | Medical services; medical diagnostic services for diagnostic or treatment purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SOTIO a.s.
- Other trademarks owned by SOTIO a.s.
- Other trademarks owned by Sotio Biotech a.s
- Other trademarks owned by SOTIO a.s.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SOTIO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 18, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 5, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 5, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 5, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 18, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jul 18, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Jul 14, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 9, 2025 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Feb 16, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 16, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 16, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 9, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 18, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 20, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 20, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 20, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 20, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 20, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 11, 2022 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Dec 3, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 3, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 3, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 3, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 3, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 21, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 18, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 18, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 15, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 24, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 24, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 9, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 27, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 9, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 24, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 24, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 20, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 4, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 4, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 4, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 21, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 15, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 15, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 15, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 15, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 15, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 6, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 6, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 1, 2018 | ALIE | ASSIGNED TO LIE | — |
| May 29, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 22, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 22, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 17, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 27, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 27, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 14, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 13, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 13, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 24, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 20, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 19, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |